Cargando…
放疗联合免疫治疗非小细胞肺癌:前沿学术问题专家交流共识
Lung cancer is the leading cause of cancer death worldwide as well as in China. For many years, conventional oncologic treatments such as surgery, chemotherapy, and radiotherapy (RT) have dominated the field of non-small cell lung cancer (NSCLC). The recent introduction of immunotherapy in clinical...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309548/ https://www.ncbi.nlm.nih.gov/pubmed/32517461 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.24 |
Ejemplares similares
-
EGFR-TKI联合放疗治疗晚期非小细胞肺癌的研究进展
Publicado: (2014) -
放疗联合阿帕替尼治疗非小细胞肺癌的机制及研究前景
Publicado: (2017) -
环状RNA在非小细胞肺癌放疗抵抗中的研究进展
Publicado: (2021) -
晚期非小细胞肺癌免疫治疗的一线联合治疗
Publicado: (2018) -
BRCA1:一种新的非小细胞肺癌放化疗疗效的预测基因
Publicado: (2012)